Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
BARDOXOLONE METHYL PREVENTS EGFR DECLINE IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 4 AND TYPE 2 DIABETES - POST-HOC ANALYSES FROM BEACON Wanner, C., Bakris, G., Block, G., Chin, M., Goldsberry, A., Inker, L., Meyer, C., O'Grady, M., Pergola, P., Warnock, D., Chertow, G. OXFORD UNIV PRESS. 2018
View details for Web of Science ID 000433059800023